Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. BCN Peptides SA
EIR
•BCN Peptides SA•October 18, 2018

BCN Peptides SA – FDA EIR, Oct 18, 2018

Record Details

An FDA pre-approval inspection of BCN Peptides SA, an Active Pharmaceutical Ingredients (API) manufacturer in Sant Quinti De Mediona, Spain, took place from October 14 to October 18, 2019. The inspection's primary objectives were to evaluate the firm's readiness for commercial manufacturing, confirm adherence to its application for an active ingredient, and audit data integrity. This assessment was conducted under CVM Compliance Program 7368.001, ensuring compliance with current Good Manufacturing Practices (CGMPs) as mandated by section 501(a)(2)(b) of the Food Drug and Cosmetic Act.

Crucially, no formal objectionable conditions or violations were identified, and consequently, no FDA Form 483 Inspectional Observations were issued. This positive outcome resulted in an approval recommendation for the application. During discussions with management, two minor areas for voluntary enhancement were noted: clarifying batch record documentation for calibrated critical process equipment and improving the assay test method's sample preparation procedures. BCN Peptides SA agreed to implement these improvements, demonstrating a commitment to maintaining robust quality systems.

Company
BCN Peptides SA
Inspection date
October 18, 2018
Product type
Drugs
Office
Office of Regulatory Affairs
Person
  • Lata C. Mathew
View Company Profile

ID · bd77e22e-4d54-4813-bb26-55b5488acbfd

Violation Codes3
FD&C Act 501(a)(2)(B)21 CFR 21121 CFR 820.50

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BCN Peptides SA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.